Yahoo Poland Wyszukiwanie w Internecie

Zaloguj się

Search results

  1. ascopubs.org › doi › 10Integrative Therapies in Cancer Care: An Update on the Guidelines

    31 maj 2024 · ASCO and the Society for Integrative Oncology have collaborated to develop guidelines for the application of integrative approaches in the management of anxiety, depression, fatigue and use of cannabinoids and cannabis in patients with cancer.

  2. ascopubs.org › doi › 10Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline...

    13 mar 2024 · In 2024, ASCO published a guideline on the use of cannabis and cannabinoids by adults with cancer. 1 The guideline provides strategies for open, nonjudgmental communication and also discusses evidence regarding cannabis and cannabinoids as cancer-directed therapy and for managing cancer symptoms and treatment side effects.

  3. link.springer.com › article › 10Multinational Association of Supportive Care in Cancer (MASCC ...

    21 lut 2023 · Inclusion criteria included randomized control trials and systematic reviews on cannabis versus placebo or active comparator in patients with cancer and psychological symptom management (anxiety, depression, and insomnia).

  4. pubmed.ncbi.nlm.nih.gov › 38430618Does medicinal cannabis affect depression, anxiety, and stress in...

    This systematic review and meta-analysis examined the efficacy and safety of medicinal cannabis, compared with any control, as an intervention for depression, anxiety, and stress symptoms in people living with cancer.

  5. acsjournals.onlinelibrary.wiley.com › doi › 10ASCO guideline on cannabis use in adults with cancer

    28 lip 2024 · An expert panel appointed by ASCO developed the guidelines to help clinicians to counsel their patients because of the strong interest in and anecdotal benefits of cannabis and cannabinoids in cancer care. Based on 13 systematic reviews and five additional primary studies, the guidelines offer some clarity on what the evidence is to date on the ...

  6. ascopubs.org › doi › 10Cannabis and Cannabinoids in Adults With Cancer: ASCO Guideline

    Cannabis and/or cannabinoid access and use by adults with cancer has outpaced the science supporting their clinical use. This guideline provides strategies for open, nonjudgmental communication between clinicians and adults with cancer about the use of cannabis and/or cannabinoids.

  7. www.sciencedirect.com › science › articleReview article Does medicinal cannabis affect depression,...

    1 cze 2024 · This systematic review and meta-analysis examined the efficacy and safety of medicinal cannabis, compared with any control, as an intervention for depression, anxiety, and stress symptoms in people living with cancer.